Mounia Beloueche‐Babari

Author

Also Known As

Beloueche-Babari, M, M Beloueche-Babari, M Beloueche‐Babari, M. Beloueche-Babari, Mounia Beloueche-Babari, Mounia Beloueche‐Babari

Publications

1.1K

Citations

H-Index

Concepts

All Affiliations

Institute of Cancer Research Cancer Research UK Royal Marsden NHS Foundation Trust Engineering and Physical Sciences Research Council National University Cancer Institute, Singapore

About

Mounia Beloueche‐Babari is an author at Institute of Cancer Research specializing in metabolomics, oncology, and tumor biology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Health Sciences	1	1	24
2	Medicine	1	1	24
3	Biochemistry	1	1	24
4	Pharmacology	1	1	24
5	Cancer Cell Biology	1	1	24

Mounia Beloueche‐Babari

Publications

Citations

H-Index

Page 1

	Year	Citations
Model Free Approach to Kinetic Analysis of Real-Time Hyperpolarized 13C Magnetic Resonance Spectroscopy Data Deborah K. Hill, Matthew Orton, Erika Mariotti, PLoS ONE	2013	166
MCT1 Inhibitor AZD3965 Increases Mitochondrial Metabolism, Facilitating Combination Therapy and Noninvasive Magnetic Resonance Spectroscopy Mounia Beloueche‐Babari, Slawomir Wantuch, Teresa Casals Galobart, Cancer Research	2017	137
Monocarboxylate transporter 1 blockade with AZD3965 inhibits lipid biosynthesis and increases tumour immune cell infiltration Mounia Beloueche‐Babari, Teresa Casals Galobart, Teresa Delgado‐Goñi, British Journal of Cancer	2020	124
Identification of magnetic resonance detectable metabolic changes associated with inhibition of phosphoinositide 3-kinase signaling in human breast cancer cells Mounia Beloueche‐Babari, L. Elizabeth Jackson, Nada M.S. Al-Saffar, Molecular Cancer Therapeutics	2006	84
Increased drug resistance is associated with reduced glucose levels and an enhanced glycolysis phenotype Bhaskar Bhattacharya, Sarah Löw, Chin Kok Soh, British Journal of Pharmacology	2014	83
Magnetic Resonance Spectroscopy Monitoring of Mitogen-Activated Protein Kinase Signaling Inhibition Mounia Beloueche‐Babari, L. Elizabeth Jackson, Nada M.S. Al-Saffar, Cancer Research	2005	80
The BRAF Inhibitor Vemurafenib Activates Mitochondrial Metabolism and Inhibits Hyperpolarized Pyruvate–Lactate Exchange in BRAF-Mutant Human Melanoma Cells Teresa Delgado‐Goñi, Maria Falck Miniotis, Slawomir Wantuch, Molecular Cancer Therapeutics	2016	55
MEK1/2 Inhibition Decreases Lactate in BRAF-Driven Human Cancer Cells Maria Falck Miniotis, Vaitha Arunan, Thomas R. Eykyn, Cancer Research	2013	51
Noninvasive Magnetic Resonance Spectroscopic Pharmacodynamic Markers of a Novel Histone Deacetylase Inhibitor, LAQ824, in Human Colon Carcinoma Cells and Xenografts Yuen‐Li Chung, Helen Troy, Rebecca Kristeleit, Neoplasia	2008	48
Increased inflammatory lipid metabolism and anaplerotic mitochondrial activation follow acquired resistance to vemurafenib in BRAF-mutant melanoma cells Teresa Delgado‐Goñi, Teresa Casals Galobart, Slawomir Wantuch, British Journal of Cancer	2019	36

Page 1